Tetravalent influenza vaccine(MDCK cell)(Wuhan Institute of Biological Products)

四价流感病毒裂解疫苗（MDCK细胞）（武汉生物制品研究所）

Report date: 2026/05/25 20:02:40

Base Information

Drug NameTetravalent influenza vaccine(MDCK cell)(Wuhan Institute of Biological Products)
Drug Alias NameN/A
ClassificationVaccines > Biological material > Viral vaccineVaccines > National Immunization Program > Non-immunization program vaccine(Class II)Vaccines > Application > Prophylactic vaccine +[4] 
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/Indicationsacute influenzaInfluenza in BirdsInfluenza, Human +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesWuhan Institute Of Biological Products Co LtdLanzhou Bailing Biotechnology Co LtdNorthwest Minzu University
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesLanzhou Bailing Biotechnology Co LtdNorthwest Minzu UniversityWuhan Institute Of Biological Products Co Ltd +[4] 
Inactive CompaniesN/A
Active Indicationsacute influenzaInfluenza in BirdsInfluenza, Human +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A